USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Technology Advancements in Precision Diagnostics and Testing
Innovation is driving the era of value-based care and enabling preventive and personalized health.
21-Dec-2023
Global
Technology Research
DACA-01-00-00-00
HC_2023_486
Precision diagnosis in today's healthcare is pivotal, tailoring treatment to individual patients based on genetic, molecular, and environmental factors. This targeted approach enhances accuracy, enables early detection and targeted treatment, minimizes trial-and-error treatment, and optimizes therapeutic outcomes.
By leveraging advanced technologies and personalized data, precision diagnosis empowers healthcare professionals to make informed decisions, improving patient care and fostering more effective and efficient healthcare delivery.
Cutting-edge precision diagnostic technologies are transforming the medical science and patient care landscape. These advanced methods meticulously analyze biological samples, such as blood, tissue, and genetic material, to accurately diagnose a range of diseases and conditions. The importance of precision diagnostic technology in healthcare lies in its ability to precisely identify diseases, reduce misdiagnoses, prevent unnecessary treatment, and enhance the effectiveness of targeted therapies. Ultimately, this contributes to improved patient outcomes.
Technology advancements around genomic sequencing, muti-omics, and AI and Big Data integration have boosted this space's growth.
This Frost & Sullivan research service focuses on identifying different emerging technologies that enable precision diagnosis, key participants working on different technologies, and the applicability of precision diagnosis across different disease areas.
Frost & Sullivan identifies 3 growth opportunities for precision diagnosis that could potentially transform the market.
Key Questions Answered
1. What are the drivers and challenges for precision diagnostics and testing development?
2. How can precision diagnosis transform diagnosis across different disease areas?
3. What does the mitochondrial therapeutics funding and partnership scenario look like?
4. Who are the main precision diagnostics and testing innovators?
5. What are the R&D trends in this space?
6. What are the key growth opportunities?
Why Is It Increasingly Difficult to Grow?The Strategic Imperative 8™: Factors Creating Pressure on Growth
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on Precision Diagnostics and Testing
Growth Opportunities Fuel the Growth Pipeline Engine™
Research Methodology
Introduction
Growth Drivers
Growth Driver Analysis
Growth Restraints
Growth Restraint Analysis
Scope and Segmentation
Utility of Precision Diagnostics
Utility of Precision Diagnostics (continued)
Liquid Biopsy in Precision Diagnosis
Liquid Biopsy in Precision Diagnosis (continued)
Liquid Biopsy in Precision Diagnosis (continued)
Predictive Genetic Testing as an Effective Tool for Precision Testing
Pharmacogenomics in Precision Diagnosis
Technological Advancements in PCR)
Emerging Technologies Bolstering Precision Testing
Emerging Technologies Enabling Precision Testing/Diagnosis
The Role of Precision Testing in Oncology
The Role of Precision Testing in Oncology (continued)
Technologies Enabling Precision Testing/Diagnosis for Oncology
Novel Biomarkers Enabling Precision Medicine
Microfluidic Devices Enabling Precision Medicine
Innovation Spotlight—Precision Testing Technology for Oncology
Recent CDx Approvals—Cancer Therapy Selection
Recent CDx Approvals—Cancer Therapy Selection (continued)
Infectious Diseases—The Need for Precision Testing
Precision Testing Enables Infectious Disease Surveillance and Management
Emerging Technologies for the Precision Testing of Infectious Diseases
Emerging Technologies for the Precision Testing of Infectious Diseases (continued)
Molecular Diagnostics Enabling Precision Testing/Diagnosis for Infectious Diseases
Multiplex Molecular POC Testing Enabling Precision Medicine
Innovation Spotlight—Precision Testing Technology for Infectious Diseases
Neurological Diseases—Challenges with Diagnostics
How Precision Testing Helps Overcome Current Diagnostic Challenges
Blood-based Biomarkers to Improve Neurodegenerative Disease Assessment
Technologies Enabling Precision Testing/Diagnosis for Neurological Diseases
Innovation Spotlight—Precision Testing Technology for Neurological Diseases
CVDs—Current Testing Challenges and the Way Forward
Molecular Diagnostics Enabling Precision Testing/Diagnosis for CVDs
Molecular Diagnostics Enabling Precision Testing/Diagnosis for CVDs (continued)
Innovation Spotlight—Precision Testing Technology for Neurological Diseases
Genetic/Rare Diseases—Challenges With Diagnosis
How Precision Testing Helps Overcome Current Diagnostic Challenges in Genetic/Rare Diseases
Technologies Enabling Precision Testing/Diagnosis for Genetic/Rare Diseases
Enablers of Precision Diagnosis
AI and ML in Precision Testing
Application
Big Data Analytics in Precision Testing
Strategic Imperatives to Bolster Precision Testing
Public and Private Funding are Promoting Precision Diagnostics Development
Public and Private Funding are Promoting Precision Diagnostics Development (continued)
Precision Diagnostics Companies’ Partnerships
Growth Opportunity 1: Increased Adoption of Genomic Screening
Growth Opportunity 1: Increased Adoption of Genomic Screening (continued)
Growth Opportunity 2: Big Data and AI Augmentation
Growth Opportunity 2: Big Data and AI Augmentation (continued)
Growth Opportunity 3: Discovery of Novel Biomarkers
Growth Opportunity 3: Discovery of Novel Biomarkers (continued)
Your Next Steps
Why Frost, Why Now?
Legal Disclaimer
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
23 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Advanced Medical Devices, Implantable and Diagnostic Solutions
The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, diagnostic solutions, and implantable.The issue features advanced medical devices such as single-breath-hold radiotherapy system, transcatheter system f...
16 Oct 2026 | Global | Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiativ...
16 Oct 2026 | Global | Technology Research
Innovations and Growth Opportunities in Precision Therapeutics, AI-Enabled Discovery and Bioengineering, Regenerative Medicine, and Next-Generation Vaccine Platforms
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming precision therapeutics, regenerative medicine, AI-enabled discovery, laboratory automation, targeted delivery, vaccines, and biomanufactu...
15 Oct 2026 | Global | Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As mo...
08 Oct 2026 | Global | Frost Radar
Frost Radar: Endoscopy Device Technology Ecosystem, 2026
The endoscopy device market is advancing toward higher-quality visualization and improved clinical decision-making, with innovation across 4K ultrahigh-definition display systems, image-enhanced endoscopy, and computer-aided detection systems. Advanced visualization is evolving through improvements ...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.